News
DGAP-News: tick Trading Software AG: Publication of the Half-Year Report FY 2021/2022
DGAP-News: Deutsche Rohstoff AG: Annual General Meeting passes all resolutions with large majority
Guidewire Survey: Insurance Customers Look to Cut Insurance Spending Due to Cost-of-living Concerns
Guidewire (NYSE: GWRE) today announced the UK results of its annual EMEA Insurance Consumer Survey, available in a whitepaper. In the face of economic pressure insurance customers may cut back on
Sistema PJSFC: Report on Payments to Governments for 2021
Offer Document Regarding Philip Morris Holland Holdings B.V.’s Recommended Cash Offer to the Shareholders of Swedish Match AB Made Public
This announcement is not an offer, whether directly or indirectly, in Australia, Hong Kong, Japan, New Zealand, or South Africa or in any other jurisdiction where such offer pursuant to legislation
Dufry releases statement on press article
Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus
Roivant Sciences and Pfizer today announced the unveiling of Priovant Therapeutics, dedicated to developing and commercializing novel therapies for autoimmune diseases with the greatest morbidity
DGAP-News: Heidelberg Pharma Reports Outcome of the Annual General Meeting 2022
DGAP-Adhoc: VERBIO Vereinigte BioEnergie AG: Significant increase in EBITDA forecast for the financial year 2021/2022 to approximately EUR 500 million - strong demand for advanced 2nd generation biofuels
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Rights and Issues Investment Trust PLC: Net Asset Value(s)
DGAP-News: Formycon AG announces amendment to the proposal for election of a Supervisory Board member (agenda item 9) in the context of the Annual General Meeting on June 30, 2022
DGAP-News: Allterco JSCo announces method and terms of dividend payment
Bureau Veritas Acquires Advanced Testing Laboratory, a US Leader in Scientific Sourcing
Bureau Veritas, a world leader in testing, inspection and certification, announced the acquisition of Advanced Testing Laboratory (ATL), a leader in scientific sourcing services for the North
Transgene and BioInvent Announce Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BT-001 in Combination with KEYTRUDA®
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq